Omalizumab Subcutaneous and Panatuss PED Drops
Determining the interaction of Omalizumab Subcutaneous and Panatuss PED Drops and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: chlophedianol / dexchlorpheniramine / pseudoephedrine
Brand name: Panatuss PED Drops, Panatuss PED, Vanacof
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Pancof HC
- Omalizumab Subcutaneous-Pancof XP
- Omalizumab Subcutaneous-Pancreatin
- Omalizumab Subcutaneous-Pancreatin 4X
- Omalizumab Subcutaneous-Pancreatin Capsules and Tablets
- Omalizumab Subcutaneous-Pancreaze
- Panatuss PED Drops-Ombitasvir, Paritaprevir, and Ritonavir
- Panatuss PED Drops-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Panatuss PED Drops-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Panatuss PED Drops-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Panatuss PED Drops-Omeclamox-Pak
- Panatuss PED Drops-Omega-3 Fatty Acid Capsules